Health
Azithromycin with QT-prolonging drugs may elevate CV event risk – Healio
According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.
However, in a large cohort, there was no diff…
According to findings published in JAMA Network Open, the combination of azithromycin and QT-prolonging drugs was associated with a 40% increase in cardiac events compared with amoxicillin and QT-prolonging drugs.
However, in a large cohort, there was no difference between use of azithromycin and amoxicillin in risk for CV events, researchers reported.
Source: Adobe Stock.
“In this large cohort study including more than 4 million episodes of both azithromycin and amoxicillin use, we found no …
-
Noosa News22 hours agoRocky waters ahead for Brisbane 2032’s Olympic rowing plan
-
General23 hours agoEV buses join Perth’s wider suburban network, ‘milestone’ for diesel phase-out
-
Noosa News20 hours agoMissing man, Maroochydore – Queensland Police News
-
General18 hours agoJordan Thompson retires from Wimbledon round-of-16 match with American Taylor Fritz